VI
ATXS

Vestcor Inc’s Astria Therapeutics ATXS Stock Holding History

Vestcor Inc’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-167,000
Closed -$2.19M – 1190
2025
Q4 		$2.19M Buy
+167,000
New +$1.99M 0.06% 309

Vestcor Inc's ATXS Position: Q1 2026 in Review

Vestcor Inc sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 167,000 shares — an estimated $2.19M sold.

Vestcor Inc first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $2.19M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Vestcor Inc reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Vestcor Inc sold 167,000 Astria Therapeutics shares in Q1 2026, an estimated $2.19M.
  • Vestcor Inc first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
  • Vestcor Inc's Astria Therapeutics position peaked at $2.19M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.